[HTML][HTML] Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
[HTML][HTML] Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive …
AK Umar, JH Zothantluanga, K Aswin… - Structural …, 2022 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
Antiviral phytocompounds "ellagic acid" and "(+)-sesamin" of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular …
AK Umar, JH Zothantluanga, K Aswin… - Structural …, 2022 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
[PDF][PDF] Antiviral phytocompounds “ellagic acid” and “(+)‑sesamin” of Bridelia retusa identified as potential inhibitors of SARS‑CoV‑2 3CL pro using extensive molecular …
AK Umar, JH Zothantluanga, K Aswin, S Maulana… - researchgate.net
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
Antiviral phytocompounds" ellagic acid" and"(+)-sesamin" of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular …
JH Zothantluanga, K Aswin, S Maulana… - Structural …, 2022 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
[PDF][PDF] Antiviral phytocompounds “ellagic acid” and “(+)‑sesamin” of Bridelia retusa identified as potential inhibitors of SARS‑CoV‑2 3CL pro using extensive molecular …
AK Umar, JH Zothantluanga, K Aswin, S Maulana… - researchgate.net
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …
has killed millions to date. Studies are being carried out to find therapeutic molecules that …